Invention is an essential feature of business. The best inventions are created when you mix talented people playing to their strengths in an environment of open collaboration, working in partnership with clients and suppliers with a clear focus on commercial goals.
Exciting and varied work that makes a difference. A collaborative culture where you can take on complex technical challenges and deliver commercial impact. That's life at TTP.
What innovations can increase the adoption of robotics more widely in the commercial sector? Rather than focus on complexity to enable such robots to operate in challenging environments, Simon Shakespeare makes the case for less sophisticated but more specialised robots working in collaborative teams.
Faced with dwindling Returns on Assets, satellite operators will increasingly look towards Internet of Things (IoT) as a potential remedy to the growing problem of broadband overcapacity.
Whilst microfluidic devices have huge potential, most fail to progress beyond research use, let alone reach mass consumer markets similar to products in the microelectronics industry. But developers are increasingly using cycles of (1) optimised designs, (2) apt manufacturing, and (3) robust testing to create highly integrated and compact devices with exciting functionality for widespread application.
Testing an automation system, a robot or a complex high-value machine for reliability is a long, expensive, and challenging part of product development. Simon Shakespeare sees a future where product design for reliability is increasingly informed by simulations and statistical approaches to testing, giving engineers confidence in a design before any hardware prototype has been committed to production.
TTP plc (TTP), a leading independent technology and product development company, today announced that its Desktop BiologyTM service has enabled the fast-track development of a novel technology in partnership with DnaNudge Ltd, the developer of the world’s first DNA-based service to “nudge” consumers towards genetically optimal buying behaviour. The technology is designed to help consumers make healthier food and drink choices based on their unique genetic profile.
TTP plc (TTP), a leading independent technology and product development company, has successfully demonstrated a reverse transcriptase-free RNA detection method.
From simple and standalone to complex and connected medical devices. We create new products and technologies for our clients. TTP will be exhibiting on booth 322 at the Drug Delivery to the Lungs Conference, 11 – 13 December 2019 at the Edinburgh International Conference Centre.
Alexander Carr, consultant at TTP plc, contributes to the latest Biocompare Article. Super resolution microscopy (SRM) takes the resolution of optical microscopy below the diffraction limit of light.
